|
|
|
Volumn 314, Issue 7091, 1997, Pages
|
|
Do neuroleptic drugs hasten cognitive decline in dementia? Trials must determine which neuroleptics are best in dementia.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN E;
APOLIPOPROTEIN E4;
NEUROLEPTIC AGENT;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEMENTIA;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
NOTE;
ANTIPSYCHOTIC AGENTS;
APOLIPOPROTEIN E4;
APOLIPOPROTEINS E;
CLINICAL TRIALS;
COGNITION DISORDERS;
DEMENTIA;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
|
|
EID: 0041195201
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
